Investing.com - MEI Pharma (NASDAQ: MEIP) reported second quarter EPS of $0.080, $0.22 better than the analyst estimate of $-0.140. Revenue for the quarter came in at $32.74M versus the consensus estimate of $5.29M.
MEI Pharma's stock price closed at $0.320. It is down -5.270% in the last 3 months and down -82.570% in the last 12 months.
MEI Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See MEI Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, MEI Pharma's Financial Health score is "weak performance".
Check out MEI Pharma's recent earnings performance, and MEI Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar